{
    "clinical_study": {
        "@rank": "48476", 
        "acronym": "PREMIERE", 
        "arm_group": [
            {
                "arm_group_label": "Remote patient monitoring", 
                "arm_group_type": "Experimental", 
                "description": "Remote patient monitoring system including the Exacerbations of Chronic Pulmonary Disease Tool (EXACT) tool can use changes in daily scores over a certain threshold level to alert notification to the clinical site. The site will contact the patient in order to determine the clinical significance associated with the change in score, and to treat the patient based on clinical judgment and clinical practice."
            }, 
            {
                "arm_group_label": "Usual care", 
                "arm_group_type": "Experimental", 
                "description": "This group of patient will continue on their usual standard care as close to real life situation as possible."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this pilot study is to evaluate a remote patient monitoring (RPM) system\n      using a daily PRO tool (EXACT = Exacerbations of Chronic Pulmonary Disease Tool), in\n      preventing hospitalization from Chronic Obstructive Pulmonary Disease (COPD) exacerbations\n      in a COPD population at high risk of exacerbation, compared to those managed by usual care."
        }, 
        "brief_title": "Compare the Effect of a Remote Monitoring System Using the EXACT Tool to Reduce Hospitalizations Due to Chronic Obstructive Pulmonary Disease (COPD) Exacerbations. EXACT = Exacerbations of Chronic Pulmonary Disease Tool.", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": "Remote Patient Monitoring in COPD Patients", 
        "condition_browse": {
            "mesh_term": [
                "Lung Diseases", 
                "Respiration Disorders", 
                "Pulmonary Disease, Chronic Obstructive", 
                "Lung Diseases, Obstructive"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study uses two parallel groups of approximately 100 patients in each arm. After a\n      screening period to confirm eligibility, patients will be randomized to either the RPM\n      system group, or the usual care group. Both groups will be followed for 52 weeks until the\n      end of study. There are only 4 planned study visits and patients  will continue on their\n      usual treatment.\n\n      The remote patient monitoring system will issue an alert to the clinical site once the\n      established threshold change has been reached. The alert notification will require the\n      clinical site to contact the patient and treat the patient based on clinical judgment and\n      clinical practice. Patients in the usual care arm will be managed through their normally\n      nurse/physician contact."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Outpatients with a diagnosis of Chronic Obstructive Pulmonary Disease (COPD), GOLD\n             grade 2 or higher as classified by the Global Initiative for Chronic Obstructive Lung\n             Disease (GOLD) guidelines, Updated 2011, including:\n\n          -  Current or ex-smokers with a smoking history of at least 10 pack years nt\n\n          -  Post-bronchodilator Forced Expiratory Volume in one second (FEV1) < 80%  of the\n             predicted normal value within 12 months prior to screening or at screening\n\n          -  Post-bronchodilator FEV1/FVC (Forced Vital Capacity) < 70% within 12 months prior to\n             screening or at screening\n\n          -  A documented history of at least 2 COPD exacerbations requiring treatment with\n             systemic corticosteroids and/or antibiotics in the previous 12 months prior to the\n             screening visit, at least one of which required hospitalization.\n\n        Exclusion criteria:\n\n          -  Use of investigational drugs at the time of enrollment, or within 30 days or 5\n             half-lives of enrollment, whichever is longer.\n\n          -  Patients who have a COPD exacerbation not clinically resolved within 30 days prior to\n             screening.\n\n          -  Patients with a history of asthma, indicated by (but not limited to) the onset of\n             respiratory symptoms suggestive of asthma (such as cough, wheezing, shortness of\n             breath) prior to age 40 years."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "118", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 4, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01744028", 
            "org_study_id": "CIDD001D2401"
        }, 
        "intervention": [
            {
                "arm_group_label": "Remote patient monitoring", 
                "description": "Remote patient monitoring system including exacerbations of chronic pulmonary disease Tool - Patient Reported Outcome (EXACT PRO), Lung Monitor, and Pulse Oximeter", 
                "intervention_name": "Remote Patient Monitoring", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Usual care", 
                "description": "Patients in the usual care arm will continue their normally established procedures of nurse/physician contact and evaluation, as is considered standard for each individual practitioner in the study.", 
                "intervention_name": "Usual care", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "COPD, remote patient monitoring, Hub, exacerbations, EXACT", 
        "lastchanged_date": "February 6, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "state": "Catalunya", 
                        "zip": "08036"
                    }, 
                    "name": "Novartis Investigative Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "state": "Catalu\u00f1a", 
                        "zip": "08035"
                    }, 
                    "name": "Novartis Investigative Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "state": "Catalu\u00f1a", 
                        "zip": "08025"
                    }, 
                    "name": "Novartis Investigative Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Girona", 
                        "country": "Spain", 
                        "state": "Catalu\u00f1a", 
                        "zip": "17007"
                    }, 
                    "name": "Novartis Investigative Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "L'Hospitalet de Llobregat", 
                        "country": "Spain", 
                        "state": "Catalu\u00f1a", 
                        "zip": "08907"
                    }, 
                    "name": "Novartis Investigative Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lerida", 
                        "country": "Spain", 
                        "state": "Catalu\u00f1a", 
                        "zip": "25198"
                    }, 
                    "name": "Novartis Investigative Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sant Boi de Llobregat", 
                        "country": "Spain", 
                        "state": "Catalu\u00f1a", 
                        "zip": "08830"
                    }, 
                    "name": "Novartis Investigative Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sant Cugat", 
                        "country": "Spain", 
                        "state": "Catalu\u00f1a", 
                        "zip": "08190"
                    }, 
                    "name": "Novartis Investigative Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sant Joan Desp\u00ed", 
                        "country": "Spain", 
                        "state": "Catalu\u00f1a", 
                        "zip": "08970"
                    }, 
                    "name": "Novartis Investigative Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Majadanonda", 
                        "country": "Spain", 
                        "state": "Madrid", 
                        "zip": "28220"
                    }, 
                    "name": "Novartis Investigative Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28034"
                    }, 
                    "name": "Novartis Investigative Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28040"
                    }, 
                    "name": "Novartis Investigative Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Torremolinos", 
                        "country": "Spain", 
                        "zip": "29620"
                    }, 
                    "name": "Novartis Investigative Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gagnef", 
                        "country": "Sweden", 
                        "zip": "785 21"
                    }, 
                    "name": "Novartis Investigative Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "G\u00f6teborg", 
                        "country": "Sweden"
                    }, 
                    "name": "Novartis Investigative Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kungshamn", 
                        "country": "Sweden", 
                        "zip": "456 31"
                    }, 
                    "name": "Novartis Investigative Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lund", 
                        "country": "Sweden", 
                        "zip": "SE-221 85"
                    }, 
                    "name": "Novartis Investigative Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lund", 
                        "country": "Sweden", 
                        "zip": "222 22"
                    }, 
                    "name": "Novartis Investigative Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stockholm", 
                        "country": "Sweden", 
                        "zip": "113 61"
                    }, 
                    "name": "Novartis Investigative Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "\u00d6stersund", 
                        "country": "Sweden", 
                        "zip": "831 83"
                    }, 
                    "name": "Novartis Investigative Site"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Spain", 
                "Sweden"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A 52-week Multi-center Randomized Trial to Evaluate Remote Patient Monitoring Using the EXACT Patient-reported Outcome Tool on Reduction of Hospitalizations From Exacerbations in Patients With Chronic Obstructive Pulmonary Disease as Compared to Those Managed by Usual Care", 
        "overall_official": {
            "affiliation": "Novartis Pharmaceuticals", 
            "last_name": "Novartis Pharmaceuticals", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Spain: Ministry of Health", 
                "Sweden: Medical Products Agency"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Comparison of the total number of hospitalizations and emergency room visits (combined) for management of Chronic Obstructive Pulmonary Disease (COPD) exacerbation(s) between the two arms", 
            "measure": "The number of hospitalizations and emergency room visits for management of COPD exacerbation(s)", 
            "safety_issue": "No", 
            "time_frame": "52 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01744028"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Comparison of the average length of hospital stay for management of COPD exacerbation(s) between the two arms.", 
                "measure": "Lenght of hospitalization", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "Comparison of the time to first occurrence of hospitalization for management of COPD exacerbation(s) between the two arms.", 
                "measure": "Time to first hospitalization", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "Comparison of the combined health care resource utilization (hospitalizations, unscheduled, scheduled office visits, telephone call contacts) for management of COPD between the two arms.", 
                "measure": "Use of health care resources", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "Comparison of the number of medical visits combined (hospitalizations, emergency room visits, unscheduled and scheduled office visits) for management of COPD between the two arms.", 
                "measure": "Number of medical visits", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }
        ], 
        "source": "Novartis", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novartis Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}